News Articles Category

  • Treatment Options for Melanoma

    September 13, 2019
    Although rare, melanoma is a type of skin cancer that develops from melanocytes, the cells that produce melanin. Melanoma has three main subtypes based on the location: Cutaneous melanoma: It occurs on the skin of areas such as the neck, arms, face, and hands. All these parts are usually exposed to sunlight. Uveal or ocular melanoma – A rare sickness that more
  • How Can the Long-term Use of Acid Reflux Drugs Cause Cancer?

    August 23, 2019
    Reflux drugs are also known as proton pump inhibitors (PPIs). They are used to heal heartburn and acid reflux; an example of such medicines are Pantoprazole, Lansoprazole, Rabeprazole, Dexlansoprazole, Omeprazole and Esomeprazole. PPIs are the most prescribed drugs in the United States. The drugs have been on sale for over 25 years. In recent years, the drugs have been more
  • 3 Risk Factors for Colon Cancer

    August 14, 2019
    Colon cancer is the third most prevalent type of cancer. It is a type of cancer that attacks the large intestines. The large intestines are the final part of the digestive system. Several risk factors can cause colon cancer. These factors can be modifiable and non-modifiable. Here are three risk factors for colon cancer: Family history – This is more
  • Suitable Screening Intervals for Low-Dose CT Lung Cancer

    July 25, 2019
    In the United States, lung cancer screening is currently offered during routine clinical care. The US Preventive Services Task Force (USPSTF) recommends that high-risk individuals go for annual low dose chest CT (LDCT) screening based on results from the National Lung Screening Trial (NLST). High-risk individuals include those between the ages of 55 and 80, have a history more
  • New Hope for Younger Women Diagnosed with Breast Cancer

    July 13, 2019
    A recent study found that adding ribociclib, a targeted drug that attacks cancer cells improved survival rates in premenopausal women diagnosed with an advanced form of breast cancer. Compared to patients that only received hormone therapy, patients prescribed ribociclib had their risk of death reduced by about a third. The drug works by specifically targeting and interfering with more
  • Physical Therapy: a Critical Component While Recovering From Breast Cancer Surgery

    June 24, 2019
    Most patients who undergo a surgical procedure also integrate physical therapy in their recovery plan, particularly, if the surgery involved body parts that move or control movement, including the legs, arms, or central nervous system. However, physical therapy is also essential to patients who’ve completed breast surgery. Whether it’s double mastectomy or lumpectomy, a great percentage of breast cancer more
  • Giving Emotional Support to Cancer Patients

    June 13, 2019
    A cancer diagnosis can have an overwhelming emotional impact not only on the individual facing the disease, but also on the person’s friends and family. Whether the affected person is your friend, child, sibling or parent, it may be challenging to find the right deeds and words to express your emotional support to them, particularly if it’s your more
  • This is How a Colonoscopy Can Prevent Colon Cancer

    May 28, 2019
    Colon or colorectal cancer is a common cancer affecting both men and women. Estimates show about 101,420 new colon cancer cases and 44,180 new cases of rectal cancer for 2019 in the United States. 2018 saw about 1.8 million new cases globally, with more of them occurring in more developed countries. It continues to affect more people but more
  • Why Choose a Texas Cancer Center?

    May 22, 2019
    Cancer continues to ravage the population, with numbers seemingly increasing by the day. Figures from the American Cancer Society show an estimated 18,750 new cases of female breast cancer, 10,950 new colorectal cancer cases, 6,280 new cases of kidney and renal pelvis cancer, 14,750 new cases of cancers of the lung and bronchus, 10,660 new cases of prostate more
  • Personalized Breast Cancer Treatment Taking Shape

    April 27, 2019
    Breast cancer affects a large number of women and as research continues, the prognosis looks better. For those with triple-negative breast cancer (TNBC), treatment is now a personalized affair, customized according to cancer subtype. The Food and Drug Administration recently approved the first immune checkpoint inhibitor for breast cancer known as atezolizumab (Tecentriq). It is to be used for unresectable locally advanced or metastatic more

More Choice Cancer Care Centers